Dynamic Variation and Reversion in the Signature Amino Acids of H7N9 Virus During Human Infection-Reference-Cited by-同舟云学术

Dynamic Variation and Reversion in the Signature Amino Acids of H7N9 Virus During Human Infection

Published:2018-04-24 Issue:4 Volume:218 Page:586-594
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Zou Xiaohui¹,Guo Qiang²,Zhang Wei³,Chen Hui²,Bai Wei³,Lu Binghuai¹,Zhang Wang¹,Fan Yanyan¹,Liu Chao¹,Wang Yeming¹,Zhou Fei¹,Cao Bin¹,

Affiliation:

1. Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, China–Japan Friendship Hospital, National Clinical Research Centre for Respiratory Disease, Beijing

2. Department of Respiratory, Emergency and Critical Care Medicine, First Affiliated Hospital of Soochow University, Jiangsu

3. First Affiliated Hospital of Nanchang University, Jiangxi, People’s Republic of China

Funder

National Science Fund

National Key Technology Support Program

Ministry of Science and Technology

13th Five-Year Jiangsu Province Health, Science and Technology Key Project

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/218/4/586/25160579/jiy217.pdf

Reference26 articles.

1. Human infection with a novel avian-origin influenza A (H7N9) virus;Gao;N Engl J Med,2013

2. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet;Zhang;Science,2013

3. Human infection with highly pathogenic avian influenza A(H7N9) virus, China;Ke;Emerg Infect Dis,2017

4. Genesis and spread of newly emerged highly pathogenic H7N9 avian viruses in Mainland China;Yang,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. V292I mutation in PB2 polymerase induces increased effects of E627K on influenza H7N9 virus replication in cells;Virus Research;2021-01

2. Next-Generation Sequencing in Clinical Virology;Application and Integration of Omics-powered Diagnostics in Clinical and Public Health Microbiology;2021

3. Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza;eBioMedicine;2020-12

4. Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus;mBio;2020-10-27

5. Research progress on human infection with avian influenza H7N9;Frontiers of Medicine;2020-01-23